semaglutide and eye floaters linked to higher risk of vision problems, FDA data analysis shows Ozempic, Wegovy (semaglutide) and rare

Results Demographic and clinical characteristics of all participants In total, 494 participants (mean age: 43 years, 71.05% male) were enrolled in this study (Table 1)

No insurance is required, no membership fees apply, and HSA/FSA accounts are eligible

Find the right GLP-1 for your body Led by board-certified physicians specializing in women's metabolic and hormone health, our clinicians prescribe based on your hormones, metabolism, and life stage

Notably, CT-388's weight loss curve had not plateaued at 48 weeks, suggesting the final treatment effect could be even higher at 72 weeks in the Phase III program

Fact #1: GLP-1s Can Contribute To Heart Health Fact #2: Clinical Trials Confirm Heart-Positive Effects Fact #3: GLP-1 Drugs Have Possible Side Effects Transcript 00:00:00:00 - 00:00:25:20 Voiceover GLP-1 drugs (Ozempic) and heart disease: 3 facts to know